| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.393 | 31.287 | 33.381 | 39.781 | 48.502 | 51.311 | 54.160 | 58.334 | 73.645 | 80.967 |
| Total Income - EUR | 30.397 | 31.290 | 33.385 | 39.785 | 48.611 | 51.315 | 54.164 | 58.339 | 73.650 | 80.976 |
| Total Expenses - EUR | 15.503 | 15.692 | 17.845 | 21.425 | 25.387 | 26.963 | 29.840 | 37.455 | 44.349 | 50.833 |
| Gross Profit/Loss - EUR | 14.893 | 15.597 | 15.540 | 18.360 | 23.224 | 24.352 | 24.324 | 20.884 | 29.301 | 30.143 |
| Net Profit/Loss - EUR | 13.981 | 15.284 | 15.206 | 17.962 | 22.739 | 23.839 | 23.782 | 20.300 | 28.565 | 27.713 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Annamarimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 869 | 505 | 124 | 0 | 0 | 0 |
| Current Assets | 17.002 | 18.002 | 17.908 | 19.594 | 23.867 | 25.545 | 26.247 | 22.888 | 33.170 | 34.964 |
| Inventories | 9 | 24 | 6 | 21 | 6 | 17 | 19 | 9 | 24 | 51 |
| Receivables | 2.150 | 2.260 | 2.360 | 3.040 | 3.781 | 3.754 | 4.208 | 4.274 | 9.922 | 96 |
| Cash | 14.843 | 15.717 | 15.543 | 16.533 | 20.080 | 21.774 | 22.020 | 18.605 | 23.224 | 34.816 |
| Shareholders Funds | 15.876 | 16.970 | 16.827 | 18.148 | 22.835 | 23.913 | 23.917 | 20.770 | 29.561 | 30.975 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.186 | 1.126 | 1.266 | 1.599 | 1.901 | 2.137 | 2.453 | 2.118 | 3.609 | 3.989 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Annamarimed S.r.l.